Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Translate Bio
Biotech
Ascidian Therapeutics rises from ATP's ocean floor with $50M
Ascidian Therapeutics has launched with $50 million in series A treasure to advance its lead asset targeting ABCA4 gene mutations.
Max Bayer
Oct 12, 2022 11:34am
Equipped with $100M in new cash, CAMP4 takes trail to the clinic
Jul 20, 2022 6:00am
Camp4 taps former Translate CMO for same role—Chutes & Ladders
Mar 18, 2022 9:30am
CAMP4 hires ex-Translate CMO, adds ex-Biogen R&D lead as adviser
Mar 14, 2022 3:25pm
Sanofi dumps mRNA COVID-19 vaccine after seeing early data
Sep 28, 2021 7:45am
Sanofi dumps Principia Biopharma's San Fran labs, cuts 38 jobs
Sep 14, 2021 11:25am
